Trial Profile
Phase II clinical trial for treating synptoms associted with Multiple-sclerosis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 23 Nov 2018
Price :
$35
*
At a glance
- Drugs Cannabidiol (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 09 Nov 2018 According to MMJ BioScience media release, study is expected to start in 2019.
- 29 Aug 2018 New trial record